{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-2.5-pro",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "388d1f38-95d9-475a-8cdf-4eb0ce090362",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "1ade59fa-20d7-4e97-98fb-b4923d767434",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "d99f5d7e-cb06-4bed-b5bc-1b8683ee7620",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "3d50e1fe-5970-43a1-a528-75a421d661f5",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon (IMG) used as an active comparator, requires reconstitution prior to administration.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "9b8c47d3-266a-40ed-a210-e2a0241ab1aa",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ce5257b2-5bdd-46dd-ad72-24c40f56f0ab",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Intravenous glucose",
        "type": {
          "id": "979dc200-20a3-4b73-b92a-8c4b9b43981e",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2f920580-d32c-4313-a031-514f6436343b",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if a patient has an insufficient response to glucagon administration, loses consciousness, or experiences symptoms of severe hypoglycemia.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "98cbba26-8384-443d-8fa0-b1e06ffbab68",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "efc4c22a-73a9-46ff-b0a2-347f021c3363",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "5647cf5d-4263-4c22-aa50-366c86d5f5ba",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Lilly"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "3ee1d717-9d45-46b8-a776-6a6a604cce27",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "0cb8ab01-1807-455f-b1b2-a8dd2b0905e5",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "22979bd6-08d3-4a07-9460-28108252dd84",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human regular insulin",
        "administrableDoseForm": {
          "id": "c2c26028-a082-40b6-bbab-8e8647c8a93f",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "b7ef374e-c872-4b2b-b218-4543aa74d6c8",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c4542ede-67e3-4296-8827-e91d39c876c4",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0.3 U/mL",
        "substanceIds": [
          "sub_3"
        ]
      },
      {
        "id": "prod_4",
        "name": "Intravenous glucose",
        "administrableDoseForm": {
          "id": "79d9c48b-7759-4b87-b065-6c2cbd74126d",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "d043567a-2a6b-4eb9-9364-d025c783eaa0",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "dff06a68-659b-4f86-b5bc-4ba11d7cb43e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 3 mg single dose",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen 1 mg single dose",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration per treatment period"
      },
      {
        "id": "admin_3",
        "name": "Human regular insulin infusion",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "doseFrequency": "Continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until bedside plasma glucose is <60 mg/dL, for a maximum of 4 hours"
      },
      {
        "id": "admin_4",
        "name": "Intravenous glucose rescue",
        "instanceType": "Administration",
        "dose": "As deemed clinically necessary",
        "doseFrequency": "As needed",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "As needed for insufficient response to glucagon"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "glucagon",
        "instanceType": "Substance",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon. Active ingredient in LY900018 and GlucaGen."
      },
      {
        "id": "sub_2",
        "name": "human regular insulin",
        "instanceType": "Substance",
        "description": "Active substance used to induce hypoglycemia."
      },
      {
        "id": "sub_3",
        "name": "glucose",
        "instanceType": "Substance",
        "description": "Active substance in the rescue medication."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal delivery device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Lilly"
      }
    ],
    "summary": {
      "interventionCount": 4,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon (LY900018) is a powder formulation of human glucagon for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon (IMG) used as an active comparator, requires reconstitution prior to administration."
      },
      {
        "name": "Human regular insulin",
        "role": "Concomitant Medication",
        "description": "Administered via IV infusion to induce hypoglycemia as part of the study procedure."
      },
      {
        "name": "Intravenous glucose",
        "role": "Rescue Medication",
        "description": "Administered if a patient has an insufficient response to glucagon administration, loses consciousness, or experiences symptoms of severe hypoglycemia."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Nasal powder",
        "strength": "3 mg",
        "manufacturer": "Lilly"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Powder for injection",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human regular insulin",
        "doseForm": "Solution for infusion",
        "strength": "0.3 U/mL",
        "manufacturer": null
      },
      {
        "name": "Intravenous glucose",
        "doseForm": "Solution for infusion",
        "strength": null,
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "glucagon",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon. Active ingredient in LY900018 and GlucaGen."
      },
      {
        "name": "human regular insulin",
        "description": "Active substance used to induce hypoglycemia."
      },
      {
        "name": "glucose",
        "description": "Active substance in the rescue medication."
      }
    ],
    "administrations": [
      {
        "name": "LY900018 3 mg single dose",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Intranasal",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "GlucaGen 1 mg single dose",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration per treatment period"
      },
      {
        "name": "Human regular insulin infusion",
        "dose": "2 mU/kg/min, adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM",
        "frequency": "Continuous infusion",
        "route": "Intravenous",
        "duration": "Until bedside plasma glucose is <60 mg/dL, for a maximum of 4 hours"
      },
      {
        "name": "Intravenous glucose rescue",
        "dose": "As deemed clinically necessary",
        "frequency": "As needed",
        "route": "Intravenous",
        "duration": "As needed for insufficient response to glucagon"
      }
    ],
    "devices": [
      {
        "name": "Nasal delivery device",
        "manufacturer": "Lilly",
        "purpose": "A single-use, nasal dosing device that is part of the LY900018 investigational drug product to deliver the contained drug constituent."
      }
    ]
  }
}